PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

Tue, 03rd Oct 2023 16:55

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

The FTSE 100 index closed down 40.56 points, or 0.5% at 7,470.16 on Tuesday. The FTSE 250 ended 299.53 points, or 1.7%, at 17,677.76. The AIM All-Share closed down 14.20 points, or 2.0%, at 703.44.

The Cboe UK 100 ended down 0.5% at 745.71, the Cboe UK 250 closed down 1.9% at 15,385.90, and the Cboe Small Companies ended down 0.6% at 12,977.63.

The number of US job openings increased 690,000 to 9.61 million on the last business day of August, from 8.92 million at the end of July, data from the US Bureau of Labor Statistics showed on Tuesday.

The print came well above market expectations, which had been expecting the number of job openings to dip to 8.8 million at the end of August, according to FXStreet-cited consensus.

The big jump in August indicated that the US labour market remains robust and further fuelled the higher for longer interest rate fears.

Nancy Vanden Houten, US lead economist at Oxford Economics, said that while the US Federal Reserve won't make policy decisions based on one JOLTS report, it does keep the risks "tilted toward another rate hike".

Currently, markets see a 30% chance of the Fed raising rates by 25 basis points at its next meeting in November, according to the CME FedWatch Tool. Just one week ago, markets saw a 16% chance of this outcome.

Hawkish comments from a senior Federal Reserve official on Monday have also helped fuel the higher for longer narrative around US interest rates.

"The most important question at this point is not whether an additional rate increase is needed this year or not, but rather how long we will need to hold rates at a sufficiently restrictive level to achieve our goals," Fed Vice Chair for Supervision Michael Barr told a conference in New York in prepared remarks.

"I expect it will take some time," he continued, adding that his decision would be guided by "a range of incoming data."

The Fed has raised its key lending rate 11 times since March 2022, lifting rates to a 22-year high as it looks to bring inflation down to its long-term target of two percent.

The dollar was stronger on Tuesday against the uncertain interest rate backdrop.

The pound was quoted at USD1.2065 at the London equities close on Tuesday, down from USD1.2143 at the London equities close on Monday. The euro stood at USD1.0459, lower against USD1.0508.

Against the yen, the dollar was trading at JPY149.22, lower compared to JPY149.78 late Monday. However, earlier on Tuesday, the dollar topped JPY150 for the first time in a year.

In London, AstraZeneca lost 0.3% after it announced it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

The pharmaceutical maker said the agreement resolves the product liability claims pending in the US District Court for the District of New Jersey, as well as in the Delaware Superior Court and the New Jersey Superior Court.

However, AstraZeneca maintains its belief that the claims are "without merit" and doesn't admit any wrongdoing in its settlement.

In the FTSE 250, Greggs closed 3.5% lower despite reporting third-quarter sales growth, thanks to a boost from its evening trading and its digital channels in the 13 weeks to September 30.

The bakery chain said total sales rose 21% year-on-year during the period, while company-managed shop like-for-like sales were up 14%.

Looking ahead, Greggs a full-year outcome in line with expectations.

RBC Brewin Dolphin analyst John Moore commented: "Greggs is proving it can be a beneficiary in tougher times, offering a price competitive option for lunch and, increasingly, evenings. The business has a strong balance sheet and is highly cash generative, which not only puts it in a good position to weather tough periods but also continue to deliver returns to shareholders...If it continues on its current roll, Greggs could find itself on the FTSE 100 in the next couple of years."

Elsewhere in London, Alfa Financial Software tumbled 12% after it announced it has terminated talks for a potential takeover by Thomas H Lee Partners.

Last Wednesday the software developer announced that it was in preliminary talks for a potential takeover with the Boston, Massachusetts-based private equity firm.

Alfa Financial did not state a reason and highlighted that the termination announcement had been made without the consent of THL.

"The board remains confident in the company's strategic direction including continued investment into the software and in high-quality people. The inherent robustness of the asset finance market, seen in the exceptionally strong late-stage pipeline, underpins our strong confidence in the outlook for the business," Alfa Financial said.

On AIM, Belluscura jumped 5.7% after it announced that it had reached an agreement with TMT Acquisition to buy the company for around GBP6.0 million.

The deal would value TMT's shares at 21.82 pence each, a 25% premium to the three-month volume weighted average price for TMT acquisition shares calculated for the period that ended on Monday.

TMT is a London-based acquisition vehicle in technology, media and telecommunications sector. Shares in firm surged 21% to 20.50p at the London equities close on Tuesday.

In European equities on Tuesday, the CAC 40 in Paris ended down 1.0%, while the DAX 40 in Frankfurt ended down 1.1%.

Stocks in New York were firmly in the red at the London equities close, with the Dow Jones Industrial Average down 1.2%, the S&P 500 index down 1.3%, and the Nasdaq Composite down 1.7%.

Brent oil was quoted at USD91.00 a barrel at the London equities close on Tuesday, up from USD90.70 at the close on Monday. Gold was quoted at USD1,824.87 an ounce, lower against USD1,833.40 at the close on Monday.

In Wednesday's UK corporate calendar, there are half-year results from grocer Tesco and a trading statement from tile retailer Topps Tiles.

The economic calendar has the latest services purchasing managers' index prints from the EU, UK and US from 0900 BST.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.